SU | ||
|---|---|---|
OUTLOOK RATING 1..100 | 79 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 33 Fair valued | |
PROFIT vs RISK RATING 1..100 | 8 | |
SMR RATING 1..100 | 48 | |
PRICE GROWTH RATING 1..100 | 39 | |
P/E GROWTH RATING 1..100 | 36 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| PATN | SU | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 67% |
| Stochastic ODDS (%) | N/A | 2 days ago 78% |
| Momentum ODDS (%) | 2 days ago 83% | 2 days ago 65% |
| MACD ODDS (%) | 2 days ago 86% | 2 days ago 65% |
| TrendWeek ODDS (%) | 2 days ago 77% | 2 days ago 69% |
| TrendMonth ODDS (%) | 2 days ago 86% | 2 days ago 67% |
| Advances ODDS (%) | N/A | 2 days ago 69% |
| Declines ODDS (%) | N/A | 11 days ago 58% |
| BollingerBands ODDS (%) | N/A | 2 days ago 67% |
| Aroon ODDS (%) | N/A | 2 days ago 71% |
A.I.dvisor tells us that PATN and GSK have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PATN and GSK's prices will move in lockstep.
| Ticker / NAME | Correlation To PATN | 1D Price Change % | ||
|---|---|---|---|---|
| PATN | 100% | N/A | ||
| GSK - PATN | 9% Poorly correlated | -2.06% | ||
| SAP - PATN | 6% Poorly correlated | +1.11% | ||
| OR - PATN | 2% Poorly correlated | -1.05% | ||
| SU - PATN | -1% Poorly correlated | +1.81% | ||
| SAN - PATN | -2% Poorly correlated | -3.98% | ||
More | ||||
A.I.dvisor indicates that over the last year, SU has been closely correlated with CVE. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if SU jumps, then CVE could also see price increases.